Daiwa Securities Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Buy |
23,648
+134
| +0.6% | +$75.2K | 0.02% | 352 |
|
|
2026
Q1 | $13.2M | Buy |
23,514
+1,024
| +5% | +$657K | 0.04% | 268 |
|
|
2025
Q4 | $15.2M | Sell |
22,490
-660
| -3% | -$449K | 0.05% | 224 |
|
|
2025
Q3 | $14.8M | Buy |
23,150
+1,852
| +9% | +$1.12M | 0.05% | 218 |
|
|
2025
Q2 | $11.4M | Buy |
21,298
+2,120
| +11% | +$1.01M | 0.04% | 252 |
|
|
2025
Q1 | $8.05M | Buy |
19,178
+1,430
| +8% | +$621K | 0.03% | 286 |
|
|
2024
Q4 | $7.34M | Buy |
17,748
+1,286
| +8% | +$564K | 0.03% | 303 |
|
|
2024
Q3 | $8.32M | Buy |
16,462
+1,510
| +10% | +$734K | 0.04% | 267 |
|
|
2024
Q2 | $7.29M | Buy |
14,952
+2,241
| +18% | +$1.13M | 0.04% | 265 |
|
|
2024
Q1 | $6.86M | Buy |
12,711
+1,045
| +9% | +$571K | 0.04% | 259 |
|
|
2023
Q4 | $6.47M | Sell |
11,666
-5,933
| -34% | -$2.79M | 0.04% | 244 |
|
|
2023
Q3 | $7.7M | Buy |
17,599
+7,193
| +69% | +$3.59M | 0.05% | 189 |
|
|
2023
Q2 | $5.23M | Sell |
10,406
-21
| -0.2% | -$10.1K | 0.03% | 266 |
|
|
2023
Q1 | $5.21M | Buy |
10,427
+464
| +5% | +$222K | 0.04% | 265 |
|
|
2022
Q4 | $4.07M | Buy |
9,963
+222
| +2% | +$86.2K | 0.03% | 304 |
|
|
2022
Q3 | $3.17M | Buy |
9,741
+401
| +4% | +$147K | 0.03% | 344 |
|
|
2022
Q2 | $3.28M | Sell |
9,340
-325
| -3% | -$133K | 0.03% | 337 |
|
|
2022
Q1 | $5.29M | Buy |
9,665
+1,005
| +12% | +$529K | 0.03% | 274 |
|
|
2021
Q4 | $5.7M | Buy |
8,660
+1,492
| +21% | +$937K | 0.03% | 261 |
|
|
2021
Q3 | $4.46M | Buy |
7,168
+535
| +8% | +$359K | 0.03% | 287 |
|
|
2021
Q2 | $4.19M | Buy |
6,633
+357
| +6% | +$197K | 0.03% | 281 |
|
|
2021
Q1 | $3.07M | Buy |
6,276
+552
| +10% | +$277K | 0.02% | 317 |
|
|
2020
Q4 | $2.86M | Buy |
5,724
+520
| +10% | +$233K | 0.02% | 313 |
|
|
2020
Q3 | $2.05M | Buy |
5,204
+1,127
| +28% | +$417K | 0.02% | 335 |
|
|
2020
Q2 | $988K | Hold |
4,077
| – | – | 0.02% | 365 |
|
|
2020
Q1 | $988K | Buy |
4,077
+178
| +5% | +$46.5K | 0.01% | 471 |
|
|
2019
Q4 | $1.02M | Sell |
3,899
-85
| -2% | -$22.4K | 0.01% | 515 |
|
|
2019
Q3 | $1.08M | Buy |
3,984
+231
| +6% | +$64.3K | 0.01% | 486 |
|
|
2019
Q2 | $1.03M | Buy |
3,753
+170
| +5% | +$41.9K | 0.01% | 477 |
|
|
2019
Q1 | $801K | Buy |
3,583
+150
| +4% | +$31K | 0.01% | 525 |
|
|
2018
Q4 | $639K | Buy |
3,433
+198
| +6% | +$40.6K | 0.01% | 534 |
|
|
2018
Q3 | $808K | Buy |
3,235
+290
| +10% | +$70.4K | 0.01% | 534 |
|
|
2018
Q2 | $642K | Hold |
2,945
| – | – | 0.01% | 588 |
|
|
2018
Q1 | $564K | Buy |
2,945
+346
| +13% | +$63.9K | ﹤0.01% | 591 |
|
|
2017
Q4 | $406K | Sell |
2,599
-3,768
| -59% | -$593K | ﹤0.01% | 671 |
|
|
2017
Q3 | $990K | Sell |
6,367
-1,383
| -18% | -$219K | 0.01% | 464 |
|
|
2017
Q2 | $1.25M | Sell |
7,750
-4,250
| -35% | -$690K | 0.01% | 408 |
|
|
2017
Q1 | $1.85M | Sell |
12,000
-3,200
| -21% | -$441K | 0.01% | 352 |
|
|
2016
Q4 | $1.78M | Buy |
15,200
+13,000
| +591% | +$1.48M | 0.01% | 296 |
|
|
2016
Q3 | $248K | Hold |
2,200
| – | – | ﹤0.01% | 639 |
|
|
2016
Q2 | $204K | Buy |
+2,200
| New | +$189K | ﹤0.01% | 663 |
|
Other funds holding IDXX
Daiwa Securities Group's IDXX Position: Q2 2026 in Review
Daiwa Securities Group increased its Idexx Laboratories (IDXX) stake by 0.57% in Q2 2026, buying an estimated $75.2K and bringing the position to 23,648 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #352.
Daiwa Securities Group first reported a position in IDXX in Q2 2016 and has held it in 41 quarters since. The position peaked at $15.2M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Daiwa Securities Group held 23,648 shares of Idexx Laboratories worth $12.4M as of Q2 2026.
- Daiwa Securities Group bought 134 Idexx Laboratories shares in Q2 2026, an estimated $75.2K.
- Idexx Laboratories made up 0.02% of Daiwa Securities Group's portfolio in Q2 2026, its #352 holding.
- Daiwa Securities Group first reported a position in Idexx Laboratories in Q2 2016 and has held it in 41 quarters since.
- Daiwa Securities Group's Idexx Laboratories position peaked at $15.2M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.